Trupanion (NASDAQ:TRUP) Upgraded at Piper Sandler

Piper Sandler upgraded shares of Trupanion (NASDAQ:TRUP) from a neutral rating to an overweight rating in a research report released on Thursday, Marketbeat reports. Piper Sandler currently has $57.00 price target on the financial services provider’s stock.

Other equities research analysts also recently issued research reports about the stock. Northland Securities boosted their target price on shares of Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research report on Thursday, October 31st. Stifel Nicolaus boosted their price objective on Trupanion from $42.00 to $44.00 and gave the company a “hold” rating in a report on Monday, January 6th. Two analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $45.33.

Trupanion Stock Performance

NASDAQ:TRUP opened at $48.90 on Thursday. Trupanion has a 1-year low of $19.69 and a 1-year high of $57.90. The firm’s fifty day moving average price is $50.52 and its 200 day moving average price is $46.10. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.66 and a quick ratio of 1.66. The firm has a market cap of $2.07 billion, a price-to-earnings ratio of -152.81, a price-to-earnings-growth ratio of 8.11 and a beta of 1.61.

Trupanion (NASDAQ:TRUP) last announced its earnings results on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.09. The business had revenue of $327.50 million during the quarter, compared to the consensus estimate of $321.79 million. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. The business’s quarterly revenue was up 14.6% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.10) earnings per share. On average, sell-side analysts expect that Trupanion will post -0.2 EPS for the current year.

Insider Activity at Trupanion

In other Trupanion news, CFO Fawwad Qureshi sold 622 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $52.61, for a total transaction of $32,723.42. Following the transaction, the chief financial officer now owns 9,867 shares of the company’s stock, valued at approximately $519,102.87. This trade represents a 5.93 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Murray B. Low sold 2,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $52.67, for a total transaction of $105,340.00. Following the transaction, the director now owns 131,513 shares in the company, valued at $6,926,789.71. This represents a 1.50 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 28,597 shares of company stock worth $1,522,082 in the last ninety days. 5.50% of the stock is owned by insiders.

Institutional Trading of Trupanion

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Quest Partners LLC purchased a new position in Trupanion in the 3rd quarter worth about $37,000. Wilmington Savings Fund Society FSB purchased a new position in shares of Trupanion in the third quarter worth approximately $54,000. GAMMA Investing LLC increased its position in shares of Trupanion by 70.4% in the third quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock worth $61,000 after acquiring an additional 596 shares in the last quarter. KBC Group NV acquired a new stake in shares of Trupanion during the fourth quarter valued at approximately $75,000. Finally, R Squared Ltd purchased a new stake in shares of Trupanion in the 4th quarter valued at approximately $79,000.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.